| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,750 |
14,000 |
$1.45M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,111 |
3,711 |
$1.11M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,742 |
5,199 |
$619K |
| 99201 |
|
2,304 |
1,755 |
$418K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,745 |
1,314 |
$222K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,482 |
772 |
$213K |
| J3490 |
Unclassified drugs |
6,543 |
3,162 |
$137K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,631 |
1,178 |
$125K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,223 |
2,149 |
$114K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,353 |
2,206 |
$112K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
971 |
948 |
$106K |
| 99070 |
|
2,696 |
2,093 |
$103K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
976 |
915 |
$99K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
2,240 |
2,232 |
$83K |
| 97139 |
|
1,838 |
361 |
$73K |
| J2704 |
Injection, propofol, 10 mg |
3,495 |
3,218 |
$71K |
| 99215 |
Prolong outpt/office vis |
1,555 |
1,263 |
$68K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,468 |
3,172 |
$61K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,183 |
2,061 |
$59K |
| 97750 |
|
490 |
253 |
$52K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
572 |
282 |
$50K |
| 80053 |
Comprehensive metabolic panel |
4,856 |
4,087 |
$47K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
732 |
715 |
$46K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,219 |
5,229 |
$44K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
964 |
375 |
$40K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
922 |
819 |
$38K |
| 71045 |
Radiologic examination, chest; single view |
2,990 |
2,372 |
$33K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,841 |
2,580 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
690 |
639 |
$28K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
985 |
962 |
$28K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,520 |
2,358 |
$27K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
199 |
164 |
$26K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,756 |
2,608 |
$26K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
70 |
67 |
$23K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
52 |
52 |
$23K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
550 |
245 |
$22K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,063 |
1,025 |
$21K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
338 |
207 |
$21K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
286 |
281 |
$20K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,748 |
1,674 |
$18K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
278 |
273 |
$17K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,161 |
2,112 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
530 |
511 |
$16K |
| 88142 |
|
3,042 |
3,027 |
$15K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,157 |
1,774 |
$15K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
218 |
215 |
$15K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
612 |
596 |
$14K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
30 |
30 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,697 |
1,500 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,584 |
1,395 |
$12K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
623 |
509 |
$8K |
| 81025 |
|
1,584 |
1,539 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
612 |
557 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
52 |
51 |
$8K |
| 93971 |
|
42 |
40 |
$7K |
| 81001 |
|
1,415 |
1,349 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
211 |
210 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
79 |
78 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
40 |
40 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
56 |
53 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
926 |
880 |
$6K |
| 96367 |
|
34 |
15 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
156 |
155 |
$5K |
| J7050 |
Infusion, normal saline solution, 250 cc |
515 |
285 |
$3K |
| 88304 |
|
298 |
248 |
$3K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
14 |
13 |
$3K |
| 83690 |
|
538 |
510 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
387 |
228 |
$3K |
| 84484 |
|
339 |
286 |
$3K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
116 |
113 |
$3K |
| 92522 |
|
13 |
13 |
$3K |
| 85610 |
|
713 |
680 |
$3K |
| 97010 |
|
56 |
12 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
59 |
57 |
$2K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
98 |
96 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
313 |
234 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
316 |
304 |
$2K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
41 |
41 |
$2K |
| 83605 |
|
184 |
168 |
$2K |
| 82948 |
|
378 |
310 |
$1K |
| 81003 |
|
603 |
586 |
$1K |
| 99152 |
|
45 |
44 |
$1K |
| 87400 |
|
50 |
48 |
$1K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
39 |
39 |
$910.12 |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$820.40 |
| 73502 |
|
13 |
12 |
$807.04 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$797.03 |
| 82962 |
|
267 |
229 |
$721.68 |
| 87581 |
|
29 |
29 |
$716.03 |
| 87486 |
|
29 |
29 |
$716.03 |
| 84443 |
Thyroid stimulating hormone (TSH) |
52 |
49 |
$635.86 |
| 45381 |
|
12 |
12 |
$580.89 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
30 |
21 |
$560.06 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
16 |
$557.62 |
| 59025 |
Fetal non-stress test |
17 |
13 |
$550.29 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
52 |
48 |
$500.55 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
43 |
42 |
$390.37 |
| 85730 |
|
80 |
74 |
$359.53 |
| 88307 |
|
12 |
12 |
$331.96 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
12 |
$260.64 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
28 |
26 |
$254.57 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25 |
24 |
$239.07 |
| 88300 |
|
48 |
45 |
$167.09 |
| 87040 |
|
13 |
12 |
$163.88 |
| 83615 |
|
31 |
29 |
$145.77 |
| 80061 |
Lipid panel |
16 |
13 |
$138.45 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
24 |
24 |
$121.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$80.40 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
44 |
41 |
$4.92 |
| 99349 |
|
14 |
13 |
$0.00 |